News
At-home testing is growing and packaging plays a big role in helping customers use them correctly to ensure accurate results.
Nexperia’s new X.PAK packaging combines high thermal performance, compact size, and easy assembly for high-power applications ...
a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and ...
Smooth integration of custom thermoformed work in process (WIP) trays with automation systems requires supply chain ...
The Healthcare Plastics Recycling Council says its multi-year research into chemical recycling for healthcare packaging shows ...
When JOA began looking to develop a never-before-seen dry molded fiber converting machine and platform, it found the ...
When JOA began looking to develop a never-before-seen dry molded fiber converting machine and platform, it found the ...
23h
News Medical on MSNAnalytichem introduces Redipor® ready-to-use culture media brand globallyBuilt on the legacy of three trusted brands - BioTrading, Redipor by Cherwell, and NEL - Redipor by AnalytiChem brings together over 150 years of prepared media expertise, innovation and heritage into ...
As tracking and supply chain transparency requirements rise, the challenges of producing compliant and correct device packaging and labelling for each respective market intensify. In the research ...
31,560 people played the daily Crossword recently. Can you solve it faster than others?31,560 people played the daily Crossword recently. Can you solve it faster than others?
Bristol-Myers Squibb has won FDA approval for the first LAG-3 inhibitor drug ahead of its rivals in cancer immunotherapy, including Merck & Co. The US regulator cleared BMS' LAG-3 drug relatlimab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results